Nasal Swab Study to Explore the Nasal Microbia
Completed
- Conditions
- Common Cold
- Registration Number
- NCT02535442
- Lead Sponsor
- Kimberly-Clark Corporation
- Brief Summary
The objective of this study is to evaluate the microbial consortia and the host inflammatory factors present in the nasal passages of patients during upper respiratory symptomology and when healthy using culture and molecular analysis techniques.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
- Adults, male or female, between the ages 18 - 60
- Exhibiting symptoms of an upper respiratory ailment, which may include runny or stuffy nose, sore throat, fever, headache, cough, malaise, or loss of appetite with no indication or intention to treat with excluded medications.
Exclusion Criteria
- Use of antibiotics, antifungals, antivirals, antihistamines, anticholinergic, anti-inflammatory, any nasal inhaled medications (other than saline), or steroid medications within the four (4) weeks prior to enrollment and during the course of the study. Use of cough suppressants and herbal medications are permitted.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Type and amount of nasal microbes Change from baseline compared to Day 21
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Spartanburg Medical Research
🇺🇸Spartanburg, South Carolina, United States